Gaucher disease
ICD-10: 5C56.0MeSH: D005776ORPHA: 683662 Treatments Available
Overview
Gaucher disease is a lysosomal storage disorder caused by pathogenic variants in the GBA1 gene, leading to deficient glucocerebrosidase activity and accumulation of glucocerebroside in macrophages. Common features include hepatosplenomegaly, anemia, thrombocytopenia, bone pain, and skeletal disease; neuronopathic forms can cause neurologic impairment. It is rare, with the non-neuronopathic type 1 form being the most common globally, and several enzyme replacement and substrate reduction therapies are documented.
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| eliglustat Orphan | Oral capsule, 84mg | FDA Approved, EMA Approved | 7 | 10d |
| Imiglucerase Orphan Cold Chain | IV infusion, 200 units/vial, 400 units/vial | FDA Approved | 6 | 14d |
Classification & Codes
ICD-10 Code
5C56.0MeSH Code
D005776Orphanet Code
ORPHA:68366Gaucher disease
| ICD-10 | 5C56.0 |
| MeSH | D005776 |
| Orphanet | ORPHA:68366 |
| Treatments | 2 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated7/24/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO